Skip to main content
. 2018 Aug 3;23(11):1349–1357. doi: 10.1634/theoncologist.2017-0692

Figure 1.

image

Diagram of patients enrolled. MRD‐directed DLI was the first choice for patients in the high‐level MRD group, and those who could not receive DLI because of patient refusal (n = 15) or provider refusal (n = 2) received interferon‐α treatment.

Abbreviations: DLI, donor lymphocyte infusion; MRD, minimal residual disease.